Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
出版年份 2020 全文链接
标题
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-25
DOI
10.1038/s41598-020-62190-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Visfatin induces the apoptosis of endothelial progenitor cells via the induction of pro-inflammatory mediators through the NF-κB pathway
- (2017) Lina Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The immunology of atherosclerosis
- (2017) Anton Gisterå et al. Nature Reviews Nephrology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
- (2017) Concepción Peiró et al. Frontiers in Pharmacology
- Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin
- (2016) Alex C. Kacso et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure: Table 1.
- (2015) Charalampos I. Liakos et al. AMERICAN JOURNAL OF HYPERTENSION
- Regulation of inflammasome activation
- (2015) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1
- (2015) Yang Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly – results from the PolSenior substudy
- (2015) Piotr Kocelak et al. Journal of the American Society of Hypertension
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury
- (2015) Sara M. Camp et al. Scientific Reports
- Endothelial NLRP3 Inflammasome Activation and Enhanced Neointima Formation in Mice by Adipokine Visfatin
- (2014) Min Xia et al. AMERICAN JOURNAL OF PATHOLOGY
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Endotoxin-induced vascular endothelial cell migration is dependent on TLR4/NF-κB pathway, NAD(P)H oxidase activation, and transient receptor potential melastatin 7 calcium channel activity
- (2014) Daniela Sarmiento et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Visfatin/Nampt induces telomere damage and senescence in human endothelial cells
- (2014) Laura A. Villalobos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases
- (2014) Alexander J.S. Choi et al. MOLECULES AND CELLS
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Visfatin/Nampt: An Adipokine with Cardiovascular Impact
- (2013) Tania Romacho et al. MEDIATORS OF INFLAMMATION
- Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
- (2013) Tania Romacho et al. PLoS One
- Effect of interleukin 1β inhibition in cardiovascular disease
- (2012) Arman Qamar et al. CURRENT OPINION IN LIPIDOLOGY
- Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus
- (2012) SEMA USLU et al. Experimental and Therapeutic Medicine
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
- (2011) Yu-Hung Chang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
- (2011) Susana Vallejo et al. PLoS One
- Membrane raft–lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin
- (2010) Min Xia et al. CARDIOVASCULAR RESEARCH
- Visfatin/PBEF/Nampt: A New Cardiovascular Target?
- (2010) Concepción Peiró et al. Frontiers in Pharmacology
- Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
- (2009) Laura Formentini et al. BIOCHEMICAL PHARMACOLOGY
- Endothelial Dysfunction
- (2009) Paul M. Vanhoutte CIRCULATION JOURNAL
- Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
- (2009) Sheng Wen Liu et al. CLINICAL ENDOCRINOLOGY
- Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
- (2009) T. Romacho et al. DIABETOLOGIA
- Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes
- (2009) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide
- (2008) Pei Wang et al. CARDIOVASCULAR RESEARCH
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD
- (2008) Nathalie Busso et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now